| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |